Cathay Biotech Inc. logo

Cathay Biotech Inc. (688065)

Market Closed
10 Aug, 06:57
SSE SSE
¥
47. 53
-1.42
-2.9009%
¥
27.94B Market Cap
- P/E Ratio
0.76% Div Yield
6.94M Volume
- Eps
¥ 48.95
Previous Close
Add Transaction
Day Range
47.37 48.86
Year Range
39.51 64.5
Want to track 688065 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688065 closed today lower at ¥47.53, a decrease of -2.9009% from yesterday's close, completing a monthly decrease of -0.5649% or -¥0.27. Over the past 12 months, 688065 stock lost -4.6157%.
688065 pays dividends to its shareholders, with the most recent payment made on Jul 29, 2026. The next estimated payment will be in In 11 months on Jul 29, 2027 for a total of ¥0.45.
The last earnings report, released on Oct 30, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Cathay Biotech Inc. has completed 1 stock splits, with the recent split occurring on Jul 20, 2022.
The company's stock is traded on one exchange.

688065 Chart

People also search for

Baoshan Iron & Steel Co., Ltd.
¥ 5.78
+0.3472%
Aluminum Corporation of China Ltd.
¥ 10.05
+2.0305%
CMOC Group Limited
¥ 20.75
-0.3841%
Ningxia Baofeng Energy Group Co., Ltd.
¥ 23.9
+0.9717%
Anhui Conch Cement Co. Ltd.
¥ 17.84
+0.4505%

Cathay Biotech Inc. (688065) FAQ

What is the stock price today?

The current price is ¥47.53.

On which exchange is it traded?

Cathay Biotech Inc. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688065.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.76%.

What is its market cap?

As of today, the market cap is 27.94B.

Has Cathay Biotech Inc. ever had a stock split?

Cathay Biotech Inc. had 1 splits and the recent split was on Jul 20, 2022.

Cathay Biotech Inc. Profile

Chemicals Industry
Materials Sector
Dr. Xiucai Liu CEO
SSE Exchange
CNE100004447 ISIN
CN Country
1,803 Employees
29 Jul 2026 Last Dividend
20 Jul 2022 Last Split
- IPO Date

Overview

Cathay Biotech Inc. is a pioneering bio-manufacturing technology company that methodically investigates, develops, produces, and markets bio-based materials on a global scale. Established in 2000 and with its headquarters in Shanghai, China, the company focuses on enhancing sustainability across a variety of industries. By implementing cutting-edge biotechnological processes, Cathay Biotech Inc. contributes to the evolution of green manufacturing solutions, making it a significant player in both the Chinese and international markets for bio-based materials.

Products and Services

  • Biological Long-Chain Diacids: The company specializes in the production of sebacic acid and octadecanedioic acid, which are key components in the manufacture of polymers, solvents, and various industrial chemicals. These bio-based diacids offer a sustainable alternative to their petroleum-derived counterparts, finding applications in high-performance products.

    Applications: Used in the production of nylons, plastics, lubricants, adhesives, and powder coatings. By opting for these bio-based diacids, industries can reduce their carbon footprint and enhance the biodegradability of their products.

  • Bio-Based Polyamides: Cathay Biotech Inc. develops and produces a range of bio-based polyamides that serve as essential materials for engineering plastics and fibers. These polyamides are designed to replace traditional, fossil fuel-based polyamides, offering improved environmental profiles and performance.

    Applications: Widely used in the automotive, electrical, and electronics sectors, as well as in consumer goods like sportswear and other textiles, providing durability, strength, and a lower environmental impact.

  • Bio-Based Pentamethylene Diamine: As an innovative product in Cathay Biotech Inc.'s portfolio, bio-based pentamethylene diamine is a key monomer for producing high-performance polyamides, offering an eco-friendly alternative to conventional diamines derived from petroleum sources.

    Applications: Its application spans across the production of high-resilience textiles, automotive parts, and various high-strength, lightweight composite materials, aligning with sustainable development goals in material engineering.

The company markets these products under the TERRYL and ECOPENT brands, catering to various sectors including textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, and consumer goods, among others. This diverse product range underscores Cathay Biotech Inc.'s commitment to sustainability and innovation in the bio-based materials industry.

Contact Information

Address: Lvzhou Ring Road, Shanghai, China
Phone: 86 21 5080 1916